Anthera discounts stock 25% to raise $33m to support blisibimod trial
This article was originally published in Scrip
Executive Summary
Anthera Pharmaceuticals offered 33 million shares of common stock at $1 per share on 19 July to raise $33 million at a 24.8% discount to the company's stock price at the end of the previous trading day.